Press Releases

Iconic office tower signs seven new tenants, two renewals, and one expansion amid multimillion-dollar renovations program

MIAMI--(BUSINESS WIRE)-- CP Group, Florida’s largest office landlord and a prominent owner-operator of office properties throughout the Sunbelt, along with DRA Advisors, today announced it has executed nearly 40,000 square feet of leasing agreements at Miami Tower — its 47-story, Class A office tower in the heart of Downtown Miami –... (continue reading...)

BUENA PARK, CA / ACCESSWIRE / May 16, 2024 / Yoshiharu Global Co. (NASDAQ: YOSH) ("Yoshiharu" or the "Company"), a California-based restaurant operator specializing in authentic Japanese ramen, announced that due to unforeseen circumstances with its former auditor, BF Borgers CPA PC ("BF Borgers"), the Company filed a Form NT 10-Q for an extension on May 15, 2024 and is in the process of engaging a new Public Company Accounting Oversight Board ("PCAOB") compliant audit... (continue reading...)

Featuring Live Demonstrations of the Optimus System, Alongside All-in-One Kestrel Integration on June 12th - 13th

MARLBOROUGH, MA / ACCESSWIRE / May 16, 2024 / Ondas Holdings Inc. (NASDAQ: ONDS) ("Ondas" or the "Company"), a leading provider of private industrial wireless networks and commercial drone and automated data solutions, announced today that its wholly owned subsidiary American Robotics Inc. ("American Robotics") will host the grand opening of its Maryland... (continue reading...)

Location set to open prior to Fall 2024 Semester

FORT LAUDERDALE, Fla., May 16, 2024 /PRNewswire/ -- Stoner's Pizza Joint, a quick-service pizza franchise, announced today that it will be opening a new corporate owned location in Clemson, SC. The unit is expected to open by August located at 1067 Tiger Boulevard, Suite 20, Clemson, SC 29631. The pizza joint will offer dine-in, take-out, and late-night delivery.

"We are thrilled to bring the Stoner's brand to... (continue reading...)

HOUSTON, May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced its abstract has been accepted for poster presentation at the EHA2024 Hybrid Congress being held June 13-16, 2024 in Madrid, Spain and virtually.

... (continue reading...)